Catalyst Wire Dossier Catalyst Wire Dossier

REGN475

REGN475 · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for REGN475, covering 2015-03-18 to 2017-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip [Phase 2, Phase 3]

See pricing